Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
Clinical trial NCT01831804 · COMPLETED
Trial details
- NCT number
- NCT01831804
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-17
- Primary completion
- 2017-02-10
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.